Real-world Outcomes of Adalimumab in Hidradenitis Suppurativa: A 10-year Retrospective Longitudinal Study
Open Access
- 1 July 2026
- journal article
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hidradenitis suppurativaThe Lancet, 2025
- European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentJournal of the European Academy of Dermatology and Venereology, 2024
- Hidradenitis suppurativa and its association with obesity, smoking, and diabetes mellitus: A systematic review and meta‐analysisInternational Wound Journal, 2024
- Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare SystemDermatology, 2020
- Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) ProjectJournal of the American Academy of Dermatology, 2020
- Two Phase 3 Trials of Adalimumab for Hidradenitis SuppurativaNew England Journal of Medicine, 2016
- Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatmentBritish Journal of Dermatology, 2014